Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primarymelanoma: results of a randomized controlled trial

Journal of Clinical Oncology

Volumn 34, Issue 36, 2016, Pages 4405-4414

  Dieng, Mbathio ^a   Butow, Phyllis N ^b   Costa, Daniel S J ^b   Morton, Rachael L ^b   Menzies, Scott W ^c,d   Mireskandari, Shab ^b   Tesson, Stephanie ^b   Mann, Graham J ^b   Cust, Anne E ^a,b   Kasparian, Nadine A ^e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; BEHAVIOR; CANCER RECURRENCE; CONTROLLED STUDY; DEPRESSION; FEAR; FEMALE; HEALTH BEHAVIOR; HIGH RISK PATIENT; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTICENTER STUDY; PATIENT-REPORTED OUTCOME; PRIMARY MELANOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOLOGICAL ADJUSTMENT; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SATISFACTION; SCORING SYSTEM; STRESS; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; MIDDLE AGED; MORTALITY; NEW SOUTH WALES; PATIENT EDUCATION; PROCEDURES; PROGNOSIS; PSYCHOLOGY; SICKNESS IMPACT PROFILE; SKIN NEOPLASMS; SURVIVOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; CONFIDENCE INTERVALS; FEAR; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEW SOUTH WALES; PATIENT EDUCATION AS TOPIC; PROGNOSIS; PSYCHOTHERAPY; SICKNESS IMPACT PROFILE; SKIN NEOPLASMS; SURVIVORS; TREATMENT OUTCOME;

EID: 85009754939     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.68.2278     Document Type: Article

References (49)

1. Australian Cancer Network. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Wellington, New South Wales, Australia, Cancer Council Australia and Australian Cancer Network, Sydney, and New Zealand Guidelines Group, 2008.
2. Boyle DA: Psychological adjustment to the melanoma experience. Semin Oncol Nurs 19:70-77, 2003.
3. Gandini S, Sera F, Cattaruzza MS, et al: Metaanalysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41:28-44, 2005.
4. Gandini S, Sera F, Cattaruzza MS, et al: Metaanalysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41:45-60, 2005.
5. Gandini S, Sera F, Cattaruzza MS, et al: Metaanalysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 41:2040-2059, 2005.
6. Youlden DR, Baade PD: The relative risk of second primary cancers in Queensland, Australia: A retrospective cohort study. BMC Cancer 11:83, 2011.
7. Bradford PT, Freedman DM, Goldstein AM, et al: Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 146: 265-272, 2010.
8. Moloney FJ, Guitera P, Coates E, et al: Detection of primary melanoma in individuals at extreme high risk: A prospective 5-year follow-up study. JAMA Dermatol, 150:819-827, 2014.
9. Kasparian NA: Psychological stress and melanoma: Are we meeting our patients' psychological needs? Clin Dermatol 31:41-46, 2013.
10. Kasparian NA, McLoone JK, Butow PN: Psychological responses and coping strategies among patients with malignant melanoma: A systematic review of the literature. Arch Dermatol 145:1415-1427, 2009.
11. Loquai C, Scheurich V, Syring N, et al: Screening for distress in routine oncological carea survey in 520 melanoma patients. PLoS One 8: e66800, 2013.
12. McLoone J, Menzies S, Meiser B, et al: Psycho-educational interventions for melanoma survivors: A systematic review. Psychooncology 22: 1444-1456, 2013.
13. McLoone J, Watts K, Menzies S, et al: When the risks are high: Psychological adjustment among melanoma survivors at high risk of developing new primary disease. Qual Health Res 22:1102-1113, 2012.
14. Simard S, Thewes B, Humphris G, et al: Fear of cancer recurrence in adult cancer survivors: A systematic review of quantitative studies. J Cancer Surviv 7:300-322, 2013.
15. Costa DS, Dieng M, Cust AE, et al: Psychometric properties of the Fear of Cancer Recurrence Inventory: An item response theory approach. Psychooncology 25:832-838, 2016.
16. Hodges LJ, Humphris GM: Fear of recurrence and psychological distress in head and neck cancer patients and their carers. Psychooncology 18:841-848, 2009.
17. Mast ME: Survivors of breast cancer: Illness uncertainty, positive reappraisal, and emotional distress. Oncol Nurs Forum 25:555-562, 1998.
18. Deimling GT, Bowman KF, Sterns S, et al: Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology 15:306-320, 2006.
19. Humphris GM, Rogers S, McNally D, et al: Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Surg 32:486-491, 2003.
20. Mirabeau-Beale KL, Kornblith AB, Penson RT, et al: Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol 114:353-359, 2009.
21. van den Beuken-van Everdingen MH, Peters ML, de Rijke JM, et al: Concerns of former breast cancer patients about disease recurrence: A validation and prevalence study. Psychooncology 17: 1137-1145, 2008.
22. Mehnert A, Berg P, Henrich G, et al: Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology 18:1273-1280, 2009.
23. Hart SL, Latini DM, Cowan JE, et al: Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer 16:161-169, 2008.
24. Mellon S, Northouse LL, Weiss LK: A population-based study of the quality of life of cancer survivors and their family caregivers. Cancer Nurs 29: 120-131, 2006; quiz 132-133.
25. Sabariego C, Brach M, Herschbach P, et al: Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients. Eur J Health Econ 12:489-497, 2011.
26. Tan JD, Butow PN, Boyle FM, et al: A qualitative assessment of psychosocial impact, coping and adjustment in high-risk melanoma patients and caregivers. Melanoma Res 24:252-260, 2014.
27. McLoone JK, Watts KJ, Menzies SW, et al: Melanoma survivors at high risk of developing new primary disease: A qualitative examination of the factors that contribute to patient satisfaction with clinical care. Psychooncology 22:1994-2000, 2013.
28. Kittler H, Weitzdorfer R, Pehamberger H, et al: Compliance with follow-up and prognosis among patients with thin melanomas. Eur J Cancer 37: 1504-1509, 2001.
29. Butow PN, Coates AS, Dunn SM: Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol 17:2256-2263, 1999.
30. Lengacher CA, Johnson-Mallard V, Post-White J, et al: Randomized controlled trial of mindfulnessbased stress reduction (MBSR) for survivors of breast cancer. Psychooncology 18:1261-1272, 2009.
31. Herschbach P, Berg P, Waadt S, et al: Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychother Psychosom 79:31-38, 2010.
32. Herschbach P, Book K, Dinkel A, et al: Evaluation of two group therapies to reduce fear of progression in cancer patients. Support Care Cancer 18:471-479, 2010.
33. Dinkel A, Herschbach P, Berg P, et al: Determinants of long-term response to group therapy for dysfunctional fear of progression in chronic diseases. Behav Med 38:1-5, 2012.
34. Butow PN, Bell ML, Smith AB, et al: Conquer fear: Protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer 13:201, 2013.
35. Dieng M, Kasparian NA, Morton RL, et al: The Melanoma Care Study: Protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease. BMC Psychol 3: 23, 2015.
36. Simard S, Savard J: Fear of Cancer Recurrence Inventory: Development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17:241-251, 2009.
37. Norman GR, Sloan JA, Wyrwich KW: Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care 41:582-592, 2003.
38. Powers BJ, Trinh JV, Bosworth HB: Can this patient read and understand written health information? JAMA 304:76-84, 2010.
39. Simard S, Savard J: Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv 9:481-491, 2015.
40. Hochberg Y: A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75: 800-802, 1988.
41. Moher D, Hopewell S, Schulz KF, et al: CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 63:e1-e37, 2010.
42. Crist JV, Grunfeld EA: Factors reported to influence fear of recurrence in cancer patients: A systematic review. Psychooncology 22:978-986, 2013.
43. Koch L, Jansen L, Brenner H, et al: Fear of recurrence and disease progression in long-term ($ 5 years) cancer survivors-a systematic review of quantitative studies. Psychooncology 22:1-11, 2013.
44. Lebel S, Ozakinci G, Humphris G, et al: Current state and future prospects of research on fear of cancer recurrence. Psychooncology 10.1002/pon.4103 [epub ahead of print on February 18, 2016].
45. Costa DS, Smith AB, Fardell JE: The sum of all fears: Conceptual challenges with measuring fear of cancer recurrence. Support Care Cancer 24: 1-3, 2016.
46. Morton RL, Rychetnik L, McCaffery K, et al: Patients' perspectives of long-term follow-up for localised cutaneous melanoma. Eur J Surg Oncol 39: 297-303, 2013.
47. Simard S, Savard J, Ivers H: Fear of cancer recurrence: Specific profiles and nature of intrusive thoughts. J Cancer Surviv 4:361-371, 2010.
48. Mustard CA, Kaufert P, Kozyrskyj A, et al: Sex differences in the use of health care services. N Engl J Med 338:1678-1683, 1998.
49. Ladwig KH, Marten-Mittag B, Formanek B, et al: Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol 16:511-518, 2000.